EBS - 3 Top Biotech Stocks to Buy Now
For stock investors, there really hasn't been anywhere to hide from the market debacle that's followed from the COVID-19 pandemic. All industries have been hit as investors dump risky assets.
It isn't too surprising that shares of biotechnology companies have fallen along with the rest, since they typically involve significant risk. On the other hand, the pandemic is drawing attention to the enormous strides the industry has made in developing new platforms for vaccines and therapeutics. We may be seeing the political threat that worried investors so much in 2019 dissolve before our very eyes as the world looks to some of these companies for help in the global crisis.
It isn't necessary to make risky and speculative bets to profit from biotech stocks in today's environment. Vertex Pharmaceuticals (NASDAQ: VRTX), Emergent BioSolutions (NYSE: EBS), and BioMarin Pharmaceutical (NASDAQ: BMRN) all have healthy and profitable growth, and are reasonably priced.